Who Buys Cyclophosphamide from India — 518 Importers Behind a $19.5M Market
India's cyclophosphamide import market is served by 518 active buyers who collectively imported $19.5M across 2,113 shipments. CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) leads with a 42.5% market share, followed by EUGIA US LLC and EUGIA US LLC,. The top 5 buyers together control 74.5% of total import value, reflecting a concentrated buyer landscape.
Top Cyclophosphamide Importers — Ranked by Import Value
CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) is the leading cyclophosphamide importer from India, holding a 42.5% share of the $19.5M market across 2,113 shipments from 518 buyers. The top 5 buyers — CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), EUGIA US LLC (UNITED STATES), EUGIA US LLC, (UNITED STATES), J. KNIPPER & COMPANY (UNITED STATES), COMMERCIAL BANK (ETHIOPIA) — collectively control 74.5% of total import value.
Top Cyclophosphamide Buyers & Importers
Ranked by import value · 518 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960X | $8.3M | 5 | 42.5% |
| 2 | EUGIA US LLCUNITED STATES CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960X | $3.4M | 5 | 17.7% |
| 3 | EUGIA US LLC,UNITED STATES CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960X | $1.9M | 5 | 9.6% |
| 4 | J. KNIPPER & COMPANYUNITED STATES CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960X | $467.5K | 5 | 2.4% |
| 5 | COMMERCIAL BANKETHIOPIA CYCLOPHOSPHAMIDE FOR INJECTION USP 1GCYCLOPHOSPHAMIDE FOR INJECTION USP 1G (CYCLOPHOSPHAMIDE FOR INJECTION 500MG BN. | $438.9K | 5 | 2.3% |
| 6 | AUROMEDICS PHARMA, LLC,.,UNITED STATES | $375.5K | 5 | 1.9% |
| 7 | AMBICA INTERNATIONAL CORPORATIONPHILIPPINES CYTOACE- 500 MG CYCLOPHOSPHAMIDE FOR INGLOTOXAN 500MG (CYCLOPHOSPHAMIDE FOR INJGLOTOXAN-500MG (CYCLOPHOSPHAMIDE FOR INJ | $269.0K | 5 | 1.4% |
| 8 | TO THEUNITED ARAB EMIRATES CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960XCYCLOPHOSPHAMIDE FOR INJECTION USP 1G | $209.4K | 5 | 1.1% |
| 9 | J KNIPPER COMPANYUNITED STATES CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960XCYCLOPHOSPHAMIDE FOR INJECTION BP 1000MG | $185.6K | 5 | 1.0% |
| 10 | HIRAD PHARMED UNITIRAN | $181.9K | 5 | 0.9% |
| 11 | XXNEAXXEU XXMITXXUNITED STATES CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960X | $181.3K | 5 | 0.9% |
| 12 | J. KNIPPER & COMPANY,UNITED STATES CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960X | $152.9K | 5 | 0.8% |
| 13 | LLC "OPTI FARM"UZBEKISTAN CYCLOPHOSPHAMIDE INJECTION CONCENTRATE 200 MG/ML ,CYCLOPHOSPHAMIDE INJECTION 200MG/ML -US ) (6960XCYCLOFOSFAN-GETWELL (CYCLOPHOSPHAMIDE FO | $147.8K | 5 | 0.8% |
| 14 | DS PHARMA PERU S.A.C.PERU CYCLOPHOSPHAMIDE FOR INJECTION BP 1000MGCYCLOPHOSPHAMIDE FOR INJECTION BP (BATCHCICLOFOSFAMIDE 50 MG CYCLOPHOSPHAMIDE T | $119.9K | 5 | 0.6% |
| 15 | CALLEX MEDICAMENTOS S. DE RL DE CVMEXICO CYATA CYCLOPHOSPHAMIDE 500MG/V AC-MEXPONFECYC 200MG INJECTION VLSPONFECYC 500MG INJECTION VLS | $88.1K | 5 | 0.5% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Cyclophosphamide — and from which countries?
Flow of Cyclophosphamide exports from India: each country's share and the named importers behind the numbers
Cyclophosphamide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $16.3M through 61 shipments. This represents a market share of 83.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $8.3M (50.7% of country's total business)
• EUGIA US LLC - $3.4M (21.1% of country's total business)
• EUGIA US LLC, - $1.9M (11.5% of country's total business)
• J. KNIPPER & COMPANY - $467.5K (2.9% of country's total business)
• AUROMEDICS PHARMA, LLC,., - $375.5K (2.3% of country's total business)
• Rest of United States's importers - $1.9M (11.5% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $267.2K, indicating premium pricing strategy compared to the market average of $9.2K.
United States is a key market for Cyclophosphamide imports, representing 83.8% of total trade value.
2Ethiopia
Ethiopia emerges as the second largest importing country, achieving a total trade value of $445.0K through 5 shipments. This represents a market share of 2.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ethiopia has a diverse importer base, with their top importers including:
• COMMERCIAL BANK - $438.9K (98.6% of country's total business)
Key Insight: Ethiopia demonstrates strong market positioning with an average shipment value of $89.0K, indicating premium pricing strategy compared to the market average of $9.2K.
Ethiopia is a key market for Cyclophosphamide imports, representing 2.3% of total trade value.
3Peru
Peru emerges as the third largest importing country, achieving a total trade value of $279.4K through 6 shipments. This represents a market share of 1.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Peru has a diverse importer base, with their top importers including:
• DS PHARMA PERU S.A.C. - $119.9K (42.9% of country's total business)
Key Insight: Peru demonstrates strong market positioning with an average shipment value of $46.6K, indicating premium pricing strategy compared to the market average of $9.2K.
Peru is a key market for Cyclophosphamide imports, representing 1.4% of total trade value.
4Philippines
Philippines emerges as the fourth largest importing country, achieving a total trade value of $277.3K through 55 shipments. This represents a market share of 1.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• AMBICA INTERNATIONAL CORPORATION - $269.0K (97.0% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $5.0K, indicating competitive pricing strategy compared to the market average of $9.2K.
Philippines is a key market for Cyclophosphamide imports, representing 1.4% of total trade value.
5Mexico
Mexico emerges as the fifth largest importing country, achieving a total trade value of $256.5K through 19 shipments. This represents a market share of 1.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Mexico has a diverse importer base, with their top importers including:
• CALLEX MEDICAMENTOS S. DE RL DE CV - $88.1K (34.3% of country's total business)
Key Insight: Mexico demonstrates strong market positioning with an average shipment value of $13.5K, indicating premium pricing strategy compared to the market average of $9.2K.
Mexico is a key market for Cyclophosphamide imports, representing 1.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Cyclophosphamide buyer market intelligence
1Buyer Segment Analysis
The importers of Cyclophosphamide from India can be categorized into several key segments:
1. Distributors: Entities such as CIPLA USA INC UPS SUPPLY CHAIN SOLU and EUGIA US LLC fall into this category. These distributors procure large quantities of Cyclophosphamide to supply to various healthcare providers, including hospitals and pharmacies. Their purchasing behavior is characterized by bulk orders and a high repeat buyer rate, reflecting ongoing demand and established supply chains.
2. Government Procurement Agencies: Organizations like the Commercial Bank in Ethiopia represent government procurement bodies. They typically engage in tender-based purchasing, aligning with national healthcare programs and policies. Their order patterns are often large-scale and periodic, corresponding with budget cycles and public health initiatives.
3. Hospital Groups and Healthcare Providers: Entities such as J. KNIPPER & COMPANY and AUROMEDICS PHARMA, LLC are indicative of this segment. These buyers procure Cyclophosphamide directly for patient treatment within their facilities. Their purchasing behavior includes regular orders to maintain adequate stock levels, ensuring uninterrupted patient care.
4. Re-exporters: Companies like AMBICA INTERNATIONAL CORPORATION in the Philippines may act as re-exporters, importing Cyclophosphamide for distribution to neighboring regions. Their order patterns can be irregular, influenced by market demand and regional distribution agreements.
5. Contract Manufacturers: Entities such as HIRAD PHARMED UNIT in Iran may function as contract manufacturers, importing Cyclophosphamide as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their purchasing behavior is typically aligned with production schedules and contractual obligations.
Country-Specific Import Regulations
TransData Nexus Cyclophosphamide buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Cyclophosphamide are as follows:
1. United States:
2. Ethiopia:
3. Peru:
4. Philippines:
5. Mexico:
Demand Drivers & Market Opportunity
TransData Nexus Cyclophosphamide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Cyclophosphamide in importing countries is driven by several factors:
1. Disease Prevalence: Cyclophosphamide is primarily used in the treatment of various cancers and autoimmune diseases. The prevalence of these conditions necessitates a consistent supply of this medication.
2. Government Healthcare Programs: Many countries have national health programs that prioritize the treatment of chronic and life-threatening diseases, leading to increased procurement of essential medicines like Cyclophosphamide.
3. Universal Health Coverage Expansion: Efforts to expand universal health coverage have resulted in greater access to essential medicines, thereby increasing demand.
4. WHO Essential Medicines List Procurement: Cyclophosphamide's inclusion in the WHO Essential Medicines List underscores its importance, prompting countries to ensure its availability through public procurement systems.
5. Tender-Based Purchasing: Many governments and large healthcare providers utilize tender-based systems to procure medicines, ensuring cost-effectiveness and consistent supply.
Our data indicates that between 2022 and 2026, 518 buyers across 114 countries imported Cyclophosphamide from India, reflecting a broad and sustained global demand for this essential medication.
Common Questions — Cyclophosphamide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest cyclophosphamide buyer importing from India?
Based on import volume and value, CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) leads with $8.3M in imports and a 42.5% market share — the highest of any single cyclophosphamide importer. EUGIA US LLC (UNITED STATES) and EUGIA US LLC, (UNITED STATES) are the next largest buyers.
QHow many companies buy cyclophosphamide from India?
There are 518 active cyclophosphamide buyers importing from India, with a combined market of $19.5M across 2,113 shipments to 114 countries. The top 5 buyers hold 74.5% of total import value, while the remaining 513 buyers handle the other 25.5%.
QWhich countries import the most cyclophosphamide from India?
The top importing countries for cyclophosphamide from India are United States (83.8%), Ethiopia (2.3%), Peru (1.4%), Philippines (1.4%), Mexico (1.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of cyclophosphamide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for cyclophosphamide from India?
The average import transaction value for cyclophosphamide from India is $9.2K, with an average unit price of $3.27 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Cyclophosphamide buyer market intelligence
1Buyer Segment Analysis
The importers of Cyclophosphamide from India can be categorized into several key segments:
1. Distributors: Entities such as CIPLA USA INC UPS SUPPLY CHAIN SOLU and EUGIA US LLC fall into this category. These distributors procure large quantities of Cyclophosphamide to supply to various healthcare providers, including hospitals and pharmacies. Their purchasing behavior is characterized by bulk orders and a high repeat buyer rate, reflecting ongoing demand and established supply chains.
2. Government Procurement Agencies: Organizations like the Commercial Bank in Ethiopia represent government procurement bodies. They typically engage in tender-based purchasing, aligning with national healthcare programs and policies. Their order patterns are often large-scale and periodic, corresponding with budget cycles and public health initiatives.
3. Hospital Groups and Healthcare Providers: Entities such as J. KNIPPER & COMPANY and AUROMEDICS PHARMA, LLC are indicative of this segment. These buyers procure Cyclophosphamide directly for patient treatment within their facilities. Their purchasing behavior includes regular orders to maintain adequate stock levels, ensuring uninterrupted patient care.
4. Re-exporters: Companies like AMBICA INTERNATIONAL CORPORATION in the Philippines may act as re-exporters, importing Cyclophosphamide for distribution to neighboring regions. Their order patterns can be irregular, influenced by market demand and regional distribution agreements.
5. Contract Manufacturers: Entities such as HIRAD PHARMED UNIT in Iran may function as contract manufacturers, importing Cyclophosphamide as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their purchasing behavior is typically aligned with production schedules and contractual obligations.
Country-Specific Import Regulations
TransData Nexus Cyclophosphamide buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Cyclophosphamide are as follows:
1. United States:
2. Ethiopia:
3. Peru:
4. Philippines:
5. Mexico:
Demand Drivers & Market Opportunity
TransData Nexus Cyclophosphamide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Cyclophosphamide in importing countries is driven by several factors:
1. Disease Prevalence: Cyclophosphamide is primarily used in the treatment of various cancers and autoimmune diseases. The prevalence of these conditions necessitates a consistent supply of this medication.
2. Government Healthcare Programs: Many countries have national health programs that prioritize the treatment of chronic and life-threatening diseases, leading to increased procurement of essential medicines like Cyclophosphamide.
3. Universal Health Coverage Expansion: Efforts to expand universal health coverage have resulted in greater access to essential medicines, thereby increasing demand.
4. WHO Essential Medicines List Procurement: Cyclophosphamide's inclusion in the WHO Essential Medicines List underscores its importance, prompting countries to ensure its availability through public procurement systems.
5. Tender-Based Purchasing: Many governments and large healthcare providers utilize tender-based systems to procure medicines, ensuring cost-effectiveness and consistent supply.
Our data indicates that between 2022 and 2026, 518 buyers across 114 countries imported Cyclophosphamide from India, reflecting a broad and sustained global demand for this essential medication.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 518 global importers of Cyclophosphamide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 2,113 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 114 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,113 Verified Shipments
518 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists